| AFCHX | CEUAX | AFCHX / CEUAX | |
| Total Expense Ratio | 2.10 | 0.85 | 247% |
| Annual Report Gross Expense Ratio | 2.10 | 0.85 | 247% |
| Fund Existence | 10 years | 24 years | - |
| Gain YTD | 3.250 | 11.570 | 28% |
| Front Load | N/A | 4% | - |
| Min. Initial Investment | 2500 | 250 | 1,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 236M | 137B | 0% |
| Annual Yield % from dividends | 0.00 | 2.51 | - |
| Returns for 1 year | 5.23 | 14.63 | 36% |
| Returns for 3 years | 19.85 | 31.79 | 62% |
| Returns for 5 years | -6.94 | -0.97 | 714% |
| Returns for 10 years | 76.17 | 67.86 | 112% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| XJH | 50.75 | 0.36 | +0.71% |
| iShares ESG Select Scrn S&P Mid-Cap ETF | |||
| NVBU | 31.32 | 0.04 | +0.11% |
| AllianzIM U.S. Equity Buffer15 UncNovETF | |||
| CRXP | 19.74 | N/A | N/A |
| Columbia Core Plus Bond ETF | |||
| SNPE | 68.90 | -0.30 | -0.43% |
| Xtrackers S&P 500 Scrd & Scrn ETF | |||
| BIB | 76.69 | -4.77 | -5.85% |
| ProShares Ultra Nasdaq Biotechnology | |||